Purpose To evaluate the characteristics of macular retinal and subfoveal choroidal changes
in patients already on taxane-based therapy by the help of spectral domain optical …

Purpose To identify common optical coherence tomography (OCT) characteristics of taxane-
related CME (T-CME) to differentiate it from CME associated with other causes (O-CME) and …

Taxane-associated maculopathy is scarcely reported in the literature but should be
considered as a known complication of intravenous use of the chemotherapy medication to …

Purpose: To investigate ophthalmic side effects of taxanes and compare side effect
frequency, requirement for cessation of taxane therapy, visual acuity outcome, and …

Background: Taxanes are drugs used in various chemotherapeutical protocols to treat solid
tumors. They have multiple systemic adverse effects, such as bone marrow suppression …

Background and purpose Although taxanes are a frequently used group of chemotherapy
agents, they can, rarely, lead to macular oedema. The purpose of this article is to review and …

Macular edema is a known side effect of taxane-based anticancer drugs. We retrospectively
investigated data from 11 centers between January 2016 and December 2021. Among …

The taxanes are chemotherapeutic agents that may, in rare cases, cause cystoid macular
edema without leakage on fluorescein angiography. Two patients with evidence of taxane …

Taxanes are a rare cause of macular edema. A 63-year-old female, under paclitaxel
treatment, was observed with progressively bilateral visual acuity loss and an apparently …

Background Paclitaxel, one of the taxanes, has been used to treat malignant tumors such as
breast cancer. It is known to cause cystic maculopathy as an unusual ocular side effect …